Latest News

No Results Found

Try adjusting your search to find what you’re looking for.


NVCA Member Spotlight: Illumina Ventures

National Venture Capital Association interviews Nick Naclerio, Founding Partner at Illumina Ventures, to learn more about the firm... Illumina Ventures invests in early-stage life science companies with a particular focus on genomics and precision health. Our team and our unique relationship with Illumina, Inc. (NASDAQ: ILMN) is what sets us apart from other firms. Our members have been both ...

Read More

Illumina Ventures Closes $325 Million Fund

Illumina Ventures, an independently managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority of the total committed capital from other strategic and financial investors, ...

Read More

Wouter Meuleman Promoted to Partner of Illumina Ventures

Illumina Ventures, an independently-managed, healthcare-focused venture firm in a strategic partnership with Illumina, Inc., today announced the promotion of Wouter Meuleman to Partner. Wouter was part of the founding team at Illumina Ventures, initially seconded from Illumina Inc., and later joined full-time in the role of Principal. He led investments in Biota Technology, Inc., Delfi Genomi...

Read More